Skip to main content

Medtronic plc. (MDT) Stock Analysis

Falling Knife setup

SellModerate Confidence

Healthcare · Medical Devices

Sell if holding. Momentum 1.1/10 is below the 5.0 floor at $80.64 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Weak growth.

Medtronic plc is a global medical device company with four segments—Cardiovascular, Neuroscience, Medical Surgical, and Diabetes—serving healthcare systems in 150+ countries. It develops, manufactures, and sells implantable devices, surgical tools, and monitoring systems;... Read more

$80.64+20.6% A.UpsideScore 5.1/10#28 of 40 Medical Devices
Stop $76.77Target $97.20(analyst − 10%)A.R:R 4.1:1
Analyst target$108.00+33.9%25 analysts
$97.20our TP
$80.64price
$108.00mean
$121

Sell if holding. Momentum 1.1/10 is below the 5.0 floor at $80.64 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Weak growth. Chart setup: Death cross, below all MAs, RSI 26, MACD bearish. Score 5.1/10, moderate confidence.

Passes 5/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity 33d clear, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: moderate.

Thesis

Rewards
Strong earnings beat streak (4/4)
Analyst upside: 21%
Risks
Weak growth
Negative momentum
Below 200-day MA

Key Metrics

P/E (TTM)22.6
P/E (Fwd)13.4
Mkt Cap$104.0B
EV/EBITDA13.1
Profit Mgn13.0%
ROE9.4%
Rev Growth8.7%
Beta0.76
Dividend3.51%
Rating analysts37

Quality Signals

Piotroski F8/9

Options Flow

P/C2.77bearish
IV36%normal
Max Pain$74-8.2% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMSuppliersole suppliers
    10-K Item 1A: 'certain components, raw materials and services needed to manufacture our products are obtained from sole suppliers'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

3 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Volume
0.0
Obv
1.0
Ma Position
1.5
Rsi
3.0
Capitulation risk (RSI 26, below 200MA)Volume distribution (falling OBV)Below 200-MA, MA slope flat

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
0.0
Revenue Growth
4.7

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
4.8
Value Rank
5.0
Quality Rank
5.9
GatesMomentum 1.1<4.5Death cross (50MA < 200MA)A.R:R 4.1 ≥ 1.5Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY 33d clearSEMI CYCLE PEAK CLEARFalling KnifeSuitability: Moderate
RSI
26 · Oversold
20D MA 50D MA 200D MADEATH CROSSSupport $78.91Resistance $88.84

Price Targets

$77
$97
A.Upside+20.5%
A.R:R4.1:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Momentum score 1.1/10 — below 4.5 minimum
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-06-03 (33d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is MDT stock a buy right now?

Sell if holding. Momentum 1.1/10 is below the 5.0 floor at $80.64 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Weak growth. Chart setup: Death cross, below all MAs, RSI 26, MACD bearish. Prior stop was $76.77. Score 5.1/10, moderate confidence.

What is the MDT stock price target?

Take-profit target: $97.20 (+20.6% upside). Prior stop was $76.77. Stop-loss: $76.77.

What are the risks of investing in MDT?

Weak growth; Negative momentum; Below 200-day MA.

Is MDT overvalued or undervalued?

Medtronic plc. trades at a P/E of 22.6 (forward 13.4). TrendMatrix value score: 6.7/10. Verdict: Sell.

What do analysts say about MDT?

37 analysts cover MDT with a consensus score of 3.8/5. Average price target: $108.

What does Medtronic plc. do?Medtronic plc is a global medical device company with four segments—Cardiovascular, Neuroscience, Medical Surgical, and...

Medtronic plc is a global medical device company with four segments—Cardiovascular, Neuroscience, Medical Surgical, and Diabetes—serving healthcare systems in 150+ countries. It develops, manufactures, and sells implantable devices, surgical tools, and monitoring systems; revenue comes from hospital and physician purchases of capital equipment and related disposables. The company has announced plans to separate its Diabetes segment.

Related stocks: GMED (Globus Medical, Inc.) · BSX (Boston Scientific Corporation) · DXCM (DexCom, Inc.) · PEN (Penumbra, Inc.) · SNN (Smith & Nephew SNATS, Inc.)